EP300 and breast neoplasm: For chemoresistance, the interaction of CD44 with p300 and SIRT1 is found to regulate β-catenin signaling and NFκB-specific transcription activity, leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor [70].